• Feedback Regulation of Cotton Gland Size and Phytoalexin Syn

  2026-06-03

  Recent research uncovers a negative feedback loop between GoPGF and JAVL that controls pigment gland size and phytoalexin production in cotton. This finding elucidates how cotton balances defense compound biosynthesis and offers new strategies for crop protection.

• NADH (Reduced Nicotinamide Adenine Dinucleotide) in Energy M

  2026-06-03

  NADH, a core coenzyme in cellular energy metabolism, acts as a central electron donor across glycolysis, the TCA cycle, and the mitochondrial electron transport chain. It serves as a sensitive biomarker for metabolic state and is crucial in disease modeling, photocatalytic cancer therapy, and redox signaling research. APExBIO supplies rigorously characterized NADH (CAS No. 58-68-4) for advanced research applications.

• Vernakalant Hydrochloride for Rapid Conversion of Atrial Fib

  2026-06-02

  This phase 3 trial assesses vernakalant hydrochloride, a novel antiarrhythmic, for the rapid pharmacological conversion of atrial fibrillation (AF). The study demonstrates that vernakalant can significantly increase conversion rates and decrease time to sinus rhythm in short-duration AF, offering a potentially safer and more efficient alternative to existing treatments.

• GM 6001 (Galardin): Empowering Precision MMP Inhibition Work

  2026-06-02

  GM 6001 (Galardin) stands out as a nanomolar-potency, broad-spectrum matrix metalloproteinase inhibitor, enabling researchers to dissect extracellular matrix dynamics across tissue repair, cancer biology, and vascular remodeling. This article delivers actionable protocols, troubleshooting insights, and translational perspectives—bridging the latest reference breakthroughs with APExBIO’s rigorously validated GM 6001 reagent.

• Ranolazine: Anti-Ischemic Agent for Cardiac Ischemia Researc

  2026-06-01

  Ranolazine empowers cardiac and metabolic research with dual action—blocking late sodium currents and optimizing substrate metabolism for unparalleled myocardial protection. This article delivers stepwise workflows, protocol enhancements, and troubleshooting tips for robust experimental outcomes. Integrating the latest mechanistic insights, it positions Ranolazine as a cornerstone for translational cardiometabolic studies.

• Sorafenib (BAY-43-9006): Applied Workflows in Cancer & Antiv

  2026-06-01

  Sorafenib (BAY-43-9006) stands out as a multikinase inhibitor bridging advanced cancer biology and emerging host-directed antiviral strategies. This article delivers protocol-level guidance, troubleshooting know-how, and insight into how APExBIO’s Sorafenib empowers both tumor and infectious disease modeling beyond standard applications.

• RITA (NSC 652287): Mechanisms and Strategy for Translational

  2026-05-31

  This thought-leadership article explores the mechanistic role and strategic application of RITA (NSC 652287) in translational cancer biology. We dissect its function as a potent MDM2-p53 interaction inhibitor, review pioneering in vitro and in vivo validation, and offer actionable guidance for researchers seeking to bridge preclinical insight with clinical potential in renal carcinoma and beyond. By integrating recent advances in assay design and translational readouts, we position RITA as a cornerstone for next-generation oncology workflows.

• Direct Mouse Genotyping Kit Plus: Precision in Macrophage Li

  2026-05-30

  Explore how the Direct Mouse Genotyping Kit Plus enables high-fidelity mouse genotyping and revolutionizes macrophage lineage tracing studies. This article uniquely dissects assay design choices in light of recent advances in hepatic immune niche biology.

• AMPK's Dual Role in Autophagy: New Insights on Energy Stress

  2026-05-29

  This article analyzes a pivotal study demonstrating that AMPK suppresses, rather than promotes, autophagy initiation during glucose starvation by inhibiting ULK1 activity. The findings reshape our understanding of energy stress adaptation and have direct methodological implications for researchers investigating autophagy regulation.

• NMDA (N-Methyl-D-aspartic acid) in Excitotoxicity Models

  2026-05-29

  NMDA (N-Methyl-D-aspartic acid) is the gold-standard agonist for modeling excitotoxic and oxidative neuronal injury in preclinical research. Leveraging APExBIO's high-purity NMDA, researchers can reliably induce and dissect calcium-dependent neurodegeneration, as demonstrated in advanced glaucoma and ferroptosis workflows.

• Direct Mouse Genotyping Kit Plus: Precision Tools for Advanc

  2026-05-28

  Discover how the Direct Mouse Genotyping Kit Plus streamlines mouse genotyping assays while enabling deeper, more reliable insights into complex disease models. This article explores advanced scientific applications and protocol nuances that go beyond standard workflows.

• Pharmacokinetics of CSBTA in MASH: Role of PXR and CYP3A Ind

  2026-05-28

  This study systematically investigates how metabolic dysfunction-associated steatohepatitis (MASH) alters the pharmacokinetics and tissue distribution of Corydalis saxicola Bunting total alkaloids (CSBTA) in mice. By integrating transporter and cytochrome P450 enzyme analyses, the work highlights the importance of PXR-mediated pathways in optimizing therapeutic dosing for MASLD/MASH.

• Angiotensin III (human, mouse): Mechanisms and Research Valu

  2026-05-27

  Angiotensin III (human, mouse) is a biologically active hexapeptide central to RAAS function, exhibiting robust aldosterone secretion and pressor activity. This peptide, supplied by APExBIO, offers validated receptor specificity and solubility characteristics vital for cardiovascular research. Current evidence positions Angiotensin III as a versatile tool for dissecting RAAS mechanisms and modeling pressor responses.

• Meropenem trihydrate: Reliable Carbapenem for Resistance Res

  2026-05-27

  This article provides a scenario-driven, evidence-based guide to leveraging Meropenem trihydrate (SKU B1217) in cell viability and resistance studies. Discover how APExBIO's reagent supports reliable workflows, interprets metabolomics data, and offers cost-efficient, reproducible protocols for antibiotic resistance and infection research.

• PreScission Protease (PSP): Tag Cleavage for Protein Purific

  2026-05-26

  PreScission Protease (PSP) is a recombinant HRV 3C protease designed for efficient and specific removal of fusion protein tags, especially GST, in protein purification workflows. It is optimal for research requiring low-temperature protease activity and minimal nonspecific cleavage. PSP should not be used for targets lacking the HRV 3C recognition site or for nonspecific proteolysis.

16130 records 1/1076 page Next 12345 下5页 Last page